Sihuan Bio to acquire 80% stake in Changyuan Pharmaceutical for 160 million yuan

央广财经··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Sihuan Bio announced plans to acquire an 80% stake in Jilin Changyuan Pharmaceutical in cash for 160 million yuan. The target company is mainly engaged in pharmaceutical production and sales, with its core product being succinylated gelatin injection. The transaction is still in the planning stage, and there is uncertainty as to whether it will ultimately be completed.

Impact on assets 1

Others▲

Off-coverage companies 1

Jilin Changyuan Pharmaceutical Co., Ltd.i
Private± MixedCapitalrelevance

Changyuan Pharmaceutical is the target of acquisition; impact depends on deal completion and terms.